|
Acute activation of the endothelium results in increased levels of active Von Willebrand Factor in HELLP syndrome.
J Thromb Haemost. 2006 Sep; Epub ahead of print Ago
Hulstein JJ, van Runnard Heimel PJ, Franx A, Lenting PJ, Bruinse HW, Silence K, de Groot PG, Fijnheer R. |
|
Acute activation of the endothelium results in increased levels of active Von Willebrand Factor in HELLP syndrome.
J Thromb Haemost. 2006 Sep; Epub ahead of print Ago
Hulstein JJ, van Runnard Heimel PJ, Franx A, Lenting PJ, Bruinse HW, Silence K, de Groot PG, Fijnheer R. |
|
Protease-activated receptors in cardiovascular diseases.
Circulation. 2006 Sep; 114(10):1070-7.
Leger AJ, Covic L, Kuliopulos A. |
|
Women and von Willebrand disease: controversies in diagnosis and management.
Semin Thromb Hemost. 2006 Sep; 32(6):605-15.
Kadir RA, Chi C. |
|
Identification of functional polymorphisms of the thromboxane A2 receptor gene in healthy volunteers.
Thromb Haemost. 2006 Sep; 96(3):356-360.
Fontana P, Gandrille S, Remones V, Dupont A, Reny JL, Aiach M, Gaussem P. |
|
Eptifibatide-eluting stent as an antiproliferative and antithrombotic agent: in vitro evaluation.
J Invasive Cardiol. 2006 Sep; 18(9):417-22.
Chitkara K, Hogrefe K, Vasa-Nicotera M, Swanson N, Gershlick AH. |
|
Fetal and neonatal thrombophilia.
Obstet Gynecol Clin North Am. 2006 Sep; 33(3):457-66. No abstract available Jul
Kenet G, Nowak-Gottl U. |
|
Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3.
Semin Thromb Hemost. 2006 Sep; 32(6):621-5.
Berntorp E. |
|
Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation.
J Thromb Haemost. 2006 Sep; 4(9):2022-7.
Altman R, Scazziota A, DE Lourdes Herrera M, Gonzalez C. |
|
Continuous infusion of coagulation factors: current opinion.
Curr Opin Hematol. 2006 Sep; 13(5):308-15.
Batorova A, Martinowitz U. |
|
The endothelial protein C receptor.
Curr Opin Hematol. . 2006 Sep; 13(5):382-85.
Esmon CT. |
|
Antithrombotic action of annexin V proved as efficient as direct inhibition of tissue factor or thrombin.
Eur J Clin Invest. 2006 Sep; 36(9):633-9.
Galan AM, van Heerde WL,Escolar G, Ordinas A, Sixma J, de Groot PG. |
|
Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms.
Curr Opin Hematol. 2006 Sep; 13(5):366-375.
Pierangeli SS, Chen PP, Gonzalez EB. |
|
Effect of phosphatidylcholine, phosphatidylethanolamine and lysophosphatidylcholine on the protein C/protein S anticoagulation system.
Blood Coagul Fibrinolysis. 2006 Sep; 17(6):453-8.
Tsuda T, Yoshimura H, Hamasaki N. |
|
Clinical significance of measuring blood coagulation factor XIIIA regularly and continuously in patients with Crohn´s disease.
J Gastroenterol Hepatol. 2006 Sep; 21(9):1407-11.
Higaki S, Nakano K, Onaka S, Amano A, Tanioka Y, Harada K, Hashimoto S, Sakaida I, Okita K. |
|
Coagulation deficiencies: a look to the future.
Haemophilia. 2006 Sep; 12(5):531-40. No abstract available Ago
Aledort LM, Lee CA. |
|
International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
Blood Coagul Fibrinolysis. 2006 Sep; 17(6):445-51.
Voves C, Wuillemin WA, Zeerleder S; International Society on Thrombosis and Haemostasis. |
|
Thrombophilia and recurrent pregnancy loss.
Obstet Gynecol Clin North Am. 2006 Sep; 33(3):429-42. No abstract available Ago
Carp HJ. |
|
Thrombophilia and the Risk for Venous Thromboembolism during Pregnancy, Delivery, and Puerperium.
Obstet Gynecol Clin North Am. 2006 Sep; 33(3):413-27. No abstract available Ago
Nelson SM, Greer IA. |
|
Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation.
J Thromb Haemost. 2006 Sep; 4(9):2022-7.
Altman R, Scazziota A, DE Lourdes Herrera M, Gonzalez C. |
